- Bullish trend confirmed on both short and long timeframes
- Trading above its 200-day moving average
- Lower volatility than the market (beta 0.71)
Green day on Thursday for iShares Nasdaq Biotechnology Index Fund
(Updated on Jun 18, 2026)
The iShares Nasdaq Biotechnology Index Fund ETF price gained 0.115% on the last trading day (Thursday, 18th Jun 2026), rising from $173.44 to $173.64. During the last trading day the ETF fluctuated 2.74% from a day low at $171.87 to a day high of $176.58. The price has risen in 6 of the last 10 days and is up by 1.29% over the past 2 weeks. Volume fell on the last day by -240 thousand shares and in total, 961 thousand shares were bought and sold for approximately $166.90 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
The ETF is moving within a horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect iShares Nasdaq Biotechnology Index Fund ETF with a 90% probability to be traded between $167.97 and $181.86 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and ETFS seldom manage to go directly from the bottom of a trend up to the top. ETFS turning up in the middle of a horizontal trend are therefore considered to be potential runners.
IBB Signals & Forecast
Mostly positive signals in the chart today. The iShares Nasdaq Biotechnology Index Fund ETF holds buy signals from both short and long-term Moving Averages giving a positive forecast for the ETF. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $171.11 and $169.61. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Monday, May 18, 2026, and so far it has risen 5.86%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The ETF should be watched closely.
Support, Risk & Stop-loss for iShares Nasdaq Biotechnology Index Fund ETF
iShares Nasdaq Biotechnology Index Fund finds support from accumulated volume at $169.37 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
In general the ETF tends to have very controlled movements and with good liquidity the risk is considered very low in this ETF. During the last day, the ETF moved $4.71 between high and low, or 2.74%. For the last week the ETF has had daily average volatility of 1.88%.
Our recommended stop-loss: $164.57 (-5.23%) (This ETF has very low daily movements and this gives very low risk. There is a buy signal from a pivot bottom found 22 days ago.)
Trading Expectations (IBB) For The Upcoming Trading Day Of Monday 22nd
For the upcoming trading day on Monday, 22nd we expect iShares Nasdaq Biotechnology Index Fund to open at $174.03, and during the day (based on 14 day Average True Range), to move between $171.81 and $175.47, which gives a possible trading interval of +/-$3.66 (+/-2.13%) up or down from last closing price. If iShares Nasdaq Biotechnology Index Fund takes out the full calculated possible swing range there will be an estimated 2.13% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $173.87 (0.13%) than the support at $169.37 (2.46%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is iShares Nasdaq Biotechnology Index Fund ETF A Buy?
Several short-term signals are positive and we conclude that the current level may hold a buying opportunity, as there is a fair chance for iShares Nasdaq Biotechnology Index Fund ETF to perform well in the short-term period.
Current score:
4.154
Buy Candidate
Unchanged
Predicted Fair Opening Price
Predicted fair opening price on June 22, 2026 - $174.03 ( 0.225%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
IBB Performance
Trading levels for IBB
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 178.74 | 2.94% |
| R2 | 176.94 | 1.90% |
| R1 | 175.83 | 1.26% |
| Price | 173.64 | |
| S1 | 172.23 | -0.81% |
| S2 | 171.12 | -1.45% |
| S3 | 169.32 | -2.49% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 175.99 | 1.35% |
| R2 | 173.99 | 0.202% |
| R1 | 173.87 | 0.132% |
| Price | 173.64 | |
| S1 | 169.37 | -2.46% |
| S2 | 169.36 | -2.46% |
| S3 | 169.06 | -2.64% |
IBB Dividend Payout History
| # | Ex-Date | Pay Date | Amount | Yield | |
|---|---|---|---|---|---|
| 1 | Jun 12, 2026 | Jun 15, 2026 | Jun 18, 2026 | $0.0238 | 0.0138% |
| 2 | Mar 17, 2026 | Mar 17, 2026 | Mar 20, 2026 | $0.122 | 0.0729% |
| 3 | Dec 15, 2025 | Dec 16, 2025 | Dec 19, 2025 | $0.183 | 0.109% |
| 4 | Sep 16, 2025 | Sep 16, 2025 | Sep 19, 2025 | $0.0828 | 0.0588% |
| 5 | Mar 17, 2025 | Mar 18, 2025 | Mar 21, 2025 | $0.121 | 0.0907% |
FAQ
Click here for our free guide on how to buy iShares Nasdaq Biotechnology Index Fund ETF.
Buy IBB